Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market
Holding RLAY?
Track your performance easily

Relay Therapeutics (RLAY) Financial Statements

397 Followers

Relay Therapeutics Financial Overview

Relay Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.523; its P/E ratio is -2.39; Relay Therapeutics is scheduled to report earnings on October 31, 2024, and the estimated EPS forecast is $-0.77. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-$ 10.01M$ -1.00K$ 25.20M$ 119.00K
Gross Profit-$ 10.01M$ -1.00K$ 25.20M$ 119.00K
EBIT$ -92.21M$ -92.19M-$ -68.13M$ -102.81M
EBITDA$ -87.18M$ -90.80M-$ -69.65M$ -103.68M
Net Income Common Stockholders$ -92.21M$ -81.39M$ -83.50M$ -68.13M$ -98.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 134.13M$ 152.87M$ 143.74M$ 151.33M$ 145.90M
Total Assets$ 772.55M$ 841.44M$ 843.98M$ 906.96M$ 962.02M
Total Debt$ 51.10M$ 52.31M$ 53.47M$ 54.60M$ 55.71M
Net Debt$ -83.03M$ -100.56M$ -90.27M$ -96.73M$ -90.19M
Total Liabilities$ 90.81M$ 95.68M$ 91.98M$ 128.59M$ 151.90M
Stockholders Equity$ 655.92M$ 745.76M$ 752.00M$ 778.37M$ 810.12M
Cash Flow-
Free Cash Flow$ -65.84M$ -52.10M-$ -75.99M$ -70.10M
Operating Cash Flow$ -65.83M$ -50.32M$ -89.19M$ -75.40M$ -68.60M
Investing Cash Flow$ 45.55M$ 10.53M$ 59.68M$ 71.36M$ 51.28M
Financing Cash Flow$ 1.54M$ 48.92M$ 21.92M$ 9.46M$ 2.08M
Currency in USD

Relay Therapeutics Earnings and Revenue History

Relay Therapeutics Debt to Assets

Relay Therapeutics Cash Flow

Relay Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis